PENN CAPITAL MANAGEMENT COMPANY, LLC – Neurocrine Biosciences, Inc. Transaction History
PENN CAPITAL MANAGEMENT COMPANY, LLC portfolio value:
$356,000
portfolio value
PENN CAPITAL MANAGEMENT COMPANY, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.39% | -154 shares | 14K | $106.21 | 3.35K |
| Q2 2022 | share | Decrease | -1.60% | -57 shares | 8K | $97.48 | 3.51K |
| Q1 2022 | share | Increase | +24.03% | 691 shares | 89K | $93.75 | 3.56K |
| Q4 2021 | share | Increase | +0.35% | 10 shares | -30K | $84.63 | 2.87K |
| Q3 2021 | share | Decrease | -4.94% | -149 shares | -18K | $95.91 | 2.86K |
| Q2 2021 | share | Decrease | -0.92% | -28 shares | -3K | $97.32 | 3.01K |
| Q1 2021 | share | Decrease | -0.36% | -11 shares | 3K | $97.25 | 3.04K |
| Q4 2020 | share | Decrease | -86.40% | -19.40K shares | -1.92M | $95.85 | 3.05K |
| Q3 2020 | share | Increase | +56.01% | 8.06K shares | 418K | $96.16 | 22.45K |
| Q2 2020 | share | Increase | 0.00% | 14.39K shares | 1.80M | $122 | 14.39K |